Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc. for Overseas Market of CAR T-Cell Products
Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
